CTRI/2023/07/055858尚未招募3 期
Comparison of Myocardial Protective effect of Sevoflurane Versus Propofol in Patients Undergoing Heart Valve Replacement Surgery A Prospective Randomized Interventional Study in Department of Anaesthesia at SMS Hospital Jaipur - nil
Department of Anaesthesiology SMS Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •NYHA class II & III
- •Ejection fraction more than 40 percent
- •No history of nervous system disease
- •Informed written consent
排除标准
- •Hypertensive Disease
- •Coronary Artery Disease
- •Infective endocarditis
- •Haematogenic and Immune Systemic Disease
- •Perioperative Steroid Therapy
研究者
相似试验
已完成
3 期
Myocardial protection in cardiac surgeryCardiopulmonary bypass.Nonrheumatic mitral valve disorder, unspecifiedI34.9IRCT20191024045227N1Iran University of Medical Sciences74
进行中（未招募）
不适用
Cardioprotective effect of sevoflurane versus propofol used during anesthesia and the postoperative period in patients undergoing coronary bypass surgery. Impact on critical care unit stay. A double-blind, randomized, controlled, prospective clinical study.Efecto cardioprotector del sevoflurano frente al propofol, utilizados durante la anestesia y el periodo postoperatorio en pacientes sometidos a cirugía de bypass coronario. Repercusión sobre la estancia en la unidad de críticos. Estudio clínico, prospectivo, controlado, randomizado y doble ciego.This study will evaluate the cardioprotective effects of sevoflurane versus propofol during anesthesia and sedation of patients undergoing coronary bypass surgery in terms of maintenance of cardiac function and reduction of stay in these units.Secondary Objectives:1. To compare the possible advantages and disadvantages of both regimens in terms of preservation/improvement or pulmonary, hepatic and renal side effects.MedDRA version: 8.1Level: LLTClassification code 10002323Term: Anesthesia generalEUCTR2006-003515-44-ESFRANCISCO JAVIER BELDA
已完成
不适用
Comparative analysis of two solutions for miocardial protection in the correction of congenital cardiopathies.Children with acyanogenic congenital heart defects operated for total correctionTraced problems - Myocardial damageSpecific descriptors - Interventricular communication, Atrioventricular communication, Right ventricle with double outlet, Tetralogy of Fallot, Myocardial protection.Q21.0Q21.2Q20.1Q21.3C14.280H02.403.670C14.280.647C14.280.671RBR-9wqbx9Hospital do Coração de Messejana Dr. Carlos Alberto Studart Gomes
招募中
3 期
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
进行中（未招募）
不适用
A comparison of Myocardial Protection Using Preconditioning with Sevoflurane Against High Thoracic Epidural Analgesia for CABG SurgeryEUCTR2005-004398-76-GBGolden Jubilee National Hospital150